[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-364998-105":59,"doc-detail-364998-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","ripk2-promotes-colorectal-cancer-metastasis-by-protecting-yap-degradation-from-itch-mediated-ubiquitination","RIPK2 promotes colorectal cancer metastasis by protecting YAP degradation from ITCH-mediated ubiquitination","","Colorectal cancer metastasis remains lethal, and this study identifies receptor-interacting protein kinase 2 (RIPK2) as an independent risk factor for poor prognosis. Single-cell RNA sequencing and spatial transcriptomics link high RIPK2 tumor-cell clusters with increased metastatic behavior and bacterial invasion. Functional experiments show RIPK2 specifically enhances migration and invasion, not proliferation. Mechanistically, RIPK2 knockdown disrupts proteolysis control of the oncoprotein YAP via ubiquitin-dependent pathways, integrating NOD2-RIPK2 signaling and ITCH-mediated K63- and K48-linked ubiquitination that promotes YAP degradation and suppresses metastasis.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/ripk2-promotes-colorectal-cancer-metastasis-by-protecting-yap-degradation-from-itch-mediated-ubiquitination/364998/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/ripk2-promotes-colorectal-cancer-metastasis-by-protecting-yap-degradation-from-itch-mediated-ubiquitination/364998.png","ImageObject",300,407,{"name":92,"@type":93},"Aurelia","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-25","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What role does RIPK2 play in colorectal cancer metastasis?","Question",{"text":112,"@type":113},"RIPK2 is identified as an independent risk factor for poor colorectal cancer prognosis and specifically promotes tumor-cell migration and invasion, supporting metastatic progression.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does RIPK2 connect to YAP degradation?",{"text":117,"@type":113},"The study shows RIPK2 knockdown increases ubiquitin-mediated proteolysis affecting YAP, indicating RIPK2 protects YAP from degradation through a regulated ubiquitination balance.",{"name":119,"@type":110,"acceptedAnswer":120},"Which pathway and E3 ubiquitin ligase mediate the mechanism?",{"text":121,"@type":113},"The mechanism links NOD2-RIPK2 signaling activated by bacterial MDP to ITCH as a critical mediator, coordinating K63-linked ubiquitination of RIPK2 and K48-linked ubiquitination of YAP.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},364998,1790211889,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":36,"preview_page_count":19,"preview_urls":145},1099514068365,"https://ap-avatar.wpscdn.com/avatar/10000253d8d9f28188e?x-image-process=image/resize,m_fixed,w_180,h_180&k=1794309523707217728","[www.nature.com/cddis](www.nature.com/cddis)  \nARTICLE OPEN   \nRIPK2 promotes colorectal cancer metastasis by protecting YAP degradation from ITCH-mediated ubiquitination  \nChen Lu1,2,10, Hongda Liu3,10, Tianyu Liu1,10, Sizheng Sun4,10, Yanan Zheng5, Tao Ling5, Xiagang Luo2, Yiming E2, Yuting Xu6, Jie Li7, Lei Liu8, Lin Miao 9, Zhengxia Liu5 and Chunzhao Yu 1,2 ✉  \n© The Author(s) 2025  \n\n| | Colorectal cancer (CRC) is the second leading cause of cancer-related death worldwide, making the exploration of metastatic mechanisms crucial for therapeutic advancements. In this study, we identiﬁed receptor-interacting protein kinase 2 (RIPK2) as an independent risk factor for poor CRC prognosis. Single-cell RNA sequencing and spatial transcriptomics revealed that a tumor cell cluster with high RIPK2 expression exhibited enhanced metastatic potential, closely linked to bacterial invasion. In vitro and in vivo experiments conﬁrmed that RIPK2 speciﬁcally promotes tumor cell migration and invasion, rather than proliferation. Proteomic analysis indicated that RIPK2 knockdown leads to increased proteolysis mediated by ubiquitin, particularly affecting the oncoprotein YAP. Additionally, bacterial invasion of epithelial cells was signiﬁcantly suppressed in RIPK2 knockdown cells, suggesting a connection to the NOD2-RIPK2 pathway, stimulated by bacterial muramyl dipeptide (MDP) . We demonstrated that MDP levels are signiﬁcantly higher in CRC tissues compared to adjacent non-cancerous tissues, correlating with RIPK2 activation. This activation triggers K63-linked ubiquitination of RIPK2, essential for NF-κB and MAPK pathway activation. Mechanistic studies identiﬁed the E3 ubiquitin ligase ITCH as a critical mediator, balancing K63-linked ubiquitination of RIPK2 and K48-linked ubiquitination of YAP, leading to YAP degradation and suppressed CRC metastasis. The stability of YAP could also be disrupted by GSK583, a pharmacological inhibitor of RIPK2, effectively suppressing CRC metastasis. Our ﬁndings provide deep insights into | |\n| --- | --- | --- |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  | RIPK2’s role in CRC progression and present a promising target for future therapeutic strategies. |  |\n|  |  |  |\n|  |  |  |\n|  | Cell Death and Disease (2025)16:248; [https://doi.org/10.1038/s41419-025-07599-9](https://doi.org/10.1038/s41419-025-07599-9) |  |\n|  |  |  |\n\nINTRODUCTION  \nColorectal cancer (CRC) is one of the common malignant tumors that threaten the health and life of humans and has high incidence and mortality rates among malignant tumors [1] . Although the overall survival (OS) rate of colorectal cancer has improved to some extent with the advancement of diagnostic and treatment technologies [2], nearly one-fourth of CRC patients have tumor metastasis at the time of initial diagnosis and around 50% undergo tumor metastasis during the treatment [3, 4] . Furthermore, the prognosis of metastatic colorectal cancer patients is very poor, with a 5-year survival rate of only 14%[5], which mainly depends on the molecular subtype of the tumor and the patient’sown health status [6] . Therefore, it is very urgent to ﬁnd genes responsible for metastatic CRC (mCRC) so that targeted therapies can be applied for CRC treatment.  \nWith the advent of robust next‑generation sequencing techniques and molecular biology techniques, numerous genes directly or indirectly linked with CRC have now been identiﬁed. Almost all  \nthese genes are protein kinases or associated with protein kinases [7–10] . This is also the case for the genes identiﬁed in other cancers. The reason that protein kinases account for a high proportion in the identiﬁed genes in cancers may be simply because protein kinases are rich genes (over 518 protein kinases presented in human, which constitute about 2% of all human genes) and especially they participate in the regulation of almost every","cbCaiuqF93ZMQJCG","https://ap.wps.com/l/cbCaiuqF93ZMQJCG","pdf",8626798,16,"English","# Introduction\n## Metastatic burden and need for targets\n## Kinases and CRC gene landscape\n## Study strategy and focus on RIPK2","[{\"question\":\"What role does RIPK2 play in colorectal cancer metastasis?\",\"answer\":\"RIPK2 is identified as an independent risk factor for poor colorectal cancer prognosis and specifically promotes tumor-cell migration and invasion, supporting metastatic progression.\"},{\"question\":\"How does RIPK2 connect to YAP degradation?\",\"answer\":\"The study shows RIPK2 knockdown increases ubiquitin-mediated proteolysis affecting YAP, indicating RIPK2 protects YAP from degradation through a regulated ubiquitination balance.\"},{\"question\":\"Which pathway and E3 ubiquitin ligase mediate the mechanism?\",\"answer\":\"The mechanism links NOD2-RIPK2 signaling activated by bacterial MDP to ITCH as a critical mediator, coordinating K63-linked ubiquitination of RIPK2 and K48-linked ubiquitination of YAP.\"}]","RIPK2 promotes colorectal cancer metastasis by protecting YAP degradation from ITCH-mediated ubiquitination | PDF",1790159662,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/80afa33e35936478d304c7c568e3e657.webp",983,1305,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/af122202cd274d1558e624811fbf57bf.webp",982,1304,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6765c37639a170721d6715d611ded55a.webp",981,1303,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5917f572063c24bf9e60825b14315b81.webp",980,1301]